Pakistan’s development challenge is not the absence of growth or reform ideas but the weak capacity of institutions to ...

If you are a bioinformatics platform lead, an ML infrastructure engineer, or a genomics budget owner who is now running ...

Revolution is the classic high-risk, high-reward biotech stock. If daraxonrasib doesn't come to market by the end of the year, the stock could easily plunge. It's important to note that the ability to ...

Nurix Therapeutics secured a partnership with Roche validating bexobrutideg and its potential as a broader platform in the ...

Antimicrobial resistance (AMR) is a significant global health threat, with its impact felt across all regions of the world.

IDEAYA Biosciences nears a 2026 melanoma drug filing, backed by strong clinical data and cash into 2030. Read why IDYA stock ...

Three-year RP data showed durable efficacy: intravitreal AAV2 optogenetics improved ~3 ETDRS lines, while lentiviral PEDF ...

It is known as the stress hormone and blamed for causing a seemingly endless list of health issues. Social media will tell ...

Experts are urging officials to rethink their decision on prostate cancer screening, after an MRI approach was shown to slash ...

Postdoctoral researcher Tarang Gaur investigates combination therapies and resistance mechanisms to improve survival outcomes ...

Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out ...

Armenian Prime Minister Nikol Pashinyan cannot see how Russia can unilaterally revise the price of its natural gas in Armenia ...